---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-004726"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2026-02-19T23:59:59+00:00"
generated_at: "2026-05-16T01:44:59.504079+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences enters $60M ATM equity distribution agreement with TD Cowen; terminates prior ATM

## Summary
- Entered equity distribution agreement with TD Cowen to sell up to $59,976,196 of common stock via ATM offerings.
- Terminated prior distribution agreement from July 2024 which had $59,976,196 unsold remaining.
- TD Cowen will receive a 3% commission on gross sales; Company reimburses certain expenses.
- Sales may occur at market prices; Company not obligated to sell any shares.
- No specific use of proceeds disclosed; Company may sell shares from time to time.

## SEC filing metadata
- accession: 0001437749-26-004726
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2026-02-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774926004726/0001437749-26-004726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926004726/plse20260218_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-004726
- JSON: https://secwatch.observer/filing/0001437749-26-004726.json
- Plain text: https://secwatch.observer/filing/0001437749-26-004726.txt

## Key facts
- Material Agreements
  PULSE BIOSCIENCES, INC. terminated Prior Distribution Agreement with the sales agents named therein valued at up to $59,976,196 (effective 2026-02-18).
  - Action: termination
  - Agreement: atm program
  - Counterparty: the sales agents named therein
  - Value: up to $59,976,196
  - Effective: 2026-02-18
  source text: Prior to the Company’s entry into the Sales Agreement, on February 18, 2026, the Company terminated its at-the-market offering program in accordance with the terms of its prior equity distribution agreement, dated as of July 15, 2024 (the “Prior Distribution Agreement”), between the Company and the sales agents named therein.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000143774926004726/0001437749-26-004726-index.htm
- Material Agreements
  PULSE BIOSCIENCES, INC. entered into Sales Agreement with TD Securities (USA) LLC valued at up to $59,976,196 (effective 2026-02-19).
  - Action: entry
  - Agreement: atm program
  - Counterparty: TD Securities (USA) LLC
  - Value: up to $59,976,196
  - Effective: 2026-02-19
  source text: On February 19, 2026, Pulse Biosciences, Inc. (the “Company”) entered into an equity distribution agreement (the “Sales Agreement”) with TD Securities (USA) LLC (“TD Cowen”) as sales agent, pursuant to which the Company may offer and sell, from time to time, through TD Cowen shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $59,976,196 (the “Shares”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000143774926004726/0001437749-26-004726-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.